Pharmacist led diabetic cardiovascular risk clinic (DCVR) - application of referral criteria

I. R. Westerhus; A. Cockburn; A. Coll; M. Kinnear

doi:10.1007/s11096-013-9801-0

Pharmacist led diabetic cardiovascular risk clinic (DCVR) - application of referral criteria

I. R. Westerhus, A. Cockburn, A. Coll, M. Kinnear

Strathclyde Institute Of Pharmacy And Biomedical Sciences

Research output: Contribution to journal › Conference Contribution

Abstract

A DCVR clinic has operated for 8 years and improves cardiovascular risk factors including the blood pressure control 1 . It is suspected that the current referral criteria defined as 'macrovascular disease' or 'nephropathy' are not applied consistently. The study objective was to explore physicians' knowledge and opinions about the clinic and obtain their views about the criteria for referral to the pharmacist.

Original language	English
Pages (from-to)	927-928
Number of pages	2
Journal	International Journal of Clinical Pharmacy
Volume	35
Issue number	5
DOIs	https://doi.org/10.1007/s11096-013-9801-0
Publication status	Published - 1 Oct 2013
Event	41st ESCP symposium on clinical pharmacy: personalised and safe therapy - Barcelona, Spain Duration: 29 Oct 2012 → 31 Oct 2012

Keywords

macrovascular disease
nephropathy
DCVR clinic

Access to Document

10.1007/s11096-013-9801-0

http://link.springer.com/article/10.1007/s11096-013-9801-0

Fingerprint Dive into the research topics of 'Pharmacist led diabetic cardiovascular risk clinic (DCVR) - application of referral criteria'. Together they form a unique fingerprint.

Cite this

@article{8c3eea024a4e4df8906ef31fc268455c,

title = "Pharmacist led diabetic cardiovascular risk clinic (DCVR) - application of referral criteria",

abstract = "A DCVR clinic has operated for 8 years and improves cardiovascular risk factors including the blood pressure control 1 . It is suspected that the current referral criteria defined as 'macrovascular disease' or 'nephropathy' are not applied consistently. The study objective was to explore physicians' knowledge and opinions about the clinic and obtain their views about the criteria for referral to the pharmacist.",

keywords = "macrovascular disease, nephropathy, DCVR clinic",

author = "Westerhus, {I. R.} and A. Cockburn and A. Coll and M. Kinnear",

year = "2013",

month = oct,

day = "1",

doi = "10.1007/s11096-013-9801-0",

language = "English",

volume = "35",

pages = "927--928",

journal = "International Journal of Clinical Pharmacy",

issn = "2210-7711",

number = "5",

note = "41st ESCP symposium on clinical pharmacy: personalised and safe therapy ; Conference date: 29-10-2012 Through 31-10-2012",

}

TY - JOUR

T1 - Pharmacist led diabetic cardiovascular risk clinic (DCVR) - application of referral criteria

AU - Westerhus, I. R.

AU - Cockburn, A.

AU - Coll, A.

AU - Kinnear, M.

PY - 2013/10/1

Y1 - 2013/10/1

N2 - A DCVR clinic has operated for 8 years and improves cardiovascular risk factors including the blood pressure control 1 . It is suspected that the current referral criteria defined as 'macrovascular disease' or 'nephropathy' are not applied consistently. The study objective was to explore physicians' knowledge and opinions about the clinic and obtain their views about the criteria for referral to the pharmacist.

AB - A DCVR clinic has operated for 8 years and improves cardiovascular risk factors including the blood pressure control 1 . It is suspected that the current referral criteria defined as 'macrovascular disease' or 'nephropathy' are not applied consistently. The study objective was to explore physicians' knowledge and opinions about the clinic and obtain their views about the criteria for referral to the pharmacist.

KW - macrovascular disease

KW - nephropathy

KW - DCVR clinic

UR - http://link.springer.com/article/10.1007/s11096-013-9801-0

U2 - 10.1007/s11096-013-9801-0

DO - 10.1007/s11096-013-9801-0

M3 - Conference Contribution

VL - 35

SP - 927

EP - 928

JO - International Journal of Clinical Pharmacy

JF - International Journal of Clinical Pharmacy

SN - 2210-7711

IS - 5

T2 - 41st ESCP symposium on clinical pharmacy: personalised and safe therapy

Y2 - 29 October 2012 through 31 October 2012

ER -